167
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Use of voriconazole in non-meningeal cryptococcosis

ORCID Icon, , , &
Pages 702-704 | Received 19 Jan 2017, Accepted 09 Mar 2017, Published online: 29 Mar 2017

References

  • Yao Y, Zhang JT, Yan B, et al. Voriconazole: a novel treatment option for cryptococcal meningitis. Infect Dis (Lond). 2015;47:694–700.
  • Zhou HX, Lu L, Chu T, et al. Skeletal cryptococcosis from 1977 to 2013. Front Microbiol. 2015;5:740.
  • Legarth RA, Christensen M, Calum H, et al. Cryptococcal rib osteomyelitis as primary and only symptom of idiopathic CD4 penia. Med Mycol Case Rep. 2014;4:16–18.
  • Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:291–322.
  • Aller AI, Martin-Mazuelos E, Lozano F, et al. Correlation of fluconazole MICs with clinical outcome in cryptococcal infection. Antimicrob Agents Chemother. 2000;44:1544–1548.
  • Srikanta D, Santiago-Tirado FH, Doering TL. Cryptococcus neoformans: historical curiosity to modern pathogen. Yeast. 2014;31:47–60.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.